# DESCRIPTION

## BACKGROUND

- motivate HIV detection
- limitations of current diagnostic methods

## SUMMARY

- introduce protein-catalyzed capture agents
- describe applications of capture agents

## Anchor Ligand

- define anchor ligand structure

### Secondary Ligand

- select secondary ligand via in situ click screen

### Tertiary and Quaternary Ligands

- select tertiary and quaternary ligands via in situ click screen

### Triazole Linkage

- describe triazole linkage between ligands

### Bilagands, Triligands and Tetraligands

- describe structures of bilagands, triligands, and tetraligands

### Properties

- describe stability of capture agents

### Detectable Labels

- list detectable labels for capture agents

## Methods and Uses

- describe method of diagnosing HIV infection
- describe method of detecting anti-gp41 antibodies
- describe use of capture agents in immunoassays

### Kits

- describe kits comprising capture agents

## Synthesis of Capture Agents

- describe method of synthesizing capture agents
- describe identification of secondary ligand
- describe identification of tertiary and quaternary ligands

## DETAILED DESCRIPTION

- define scope and terminology

### DEFINITIONS

- define amino radical
- define cyano radical
- define hydroxy radical
- define imino substituent
- define nitro radical
- define oxo substituent
- define thioxo substituent
- define alkyl radical
- define alkylene chain
- define alkoxy radical
- define aminocarbonyl radical
- define alpha-amino carbonyl radical
- define alpha-amido carbonyl radical
- define aryl radical
- define aralkyl radical
- define heterocyclyl radical
- define prodrug
- define invention scope
- introduce metabolic products
- define mammal
- define optional
- define pharmaceutically acceptable carrier
- define pharmaceutically acceptable salt
- describe stereoisomers
- describe tautomers
- describe solvates
- define capture agent
- define epitope
- define polypeptide
- define amino acid
- define non-natural amino acid
- describe specific binding
- define KD
- define kd
- define ka
- define pharmaceutical composition
- define condition
- define treat
- define antibody

### Development of Anti-Gp41 Antibody Capture Agents

- motivate replacement of antibodies
- describe limitations of antibodies
- introduce in situ click chemistry
- describe sequential in situ click chemistry
- apply sequential in situ click chemistry to anti-gp41 antibodies

### Anti-Gp41 Antibody Capture Agents

- define biligand capture agents
- describe target-binding moieties
- specify anchor and secondary ligands
- describe linkages between ligands
- describe stability of capture agents
- describe detection labels

### Methods of Making/Screening Capture Agents

- identify anchor ligand
- identify secondary ligand
- identify tertiary ligand
- identify quarternary ligand
- describe optional modifications
- describe screening process

### Methods for Targeting Specific Antibodies

- motivate approach
- describe approach
- describe screening and testing

### In Vitro

- describe in vitro detection assays

### Diagnostic Imaging

- describe diagnostic imaging applications

### Therapeutic Applications

- introduce antibody capture agents
- diagnose HIV infections
- link therapeutic agents

## EXAMPLES

### Example 1

- introduce antibody-targeted PCC development
- describe anchor peptide design
- outline in situ click screen process
- summarize PCC agent development

### Example 2

- evaluate antibody-targeting peptides
- describe immunoprecipitation and ELISA assays
- summarize performance of PCC agents
- test thermal stability of PCC agents

### Example 3

- describe anchor synthesis

### Example 4

- outline screening against 3D6
- describe preclear, target, anti-screen, and product screens
- summarize screening results

### Example 5

- describe screening against 4B3

### Example 6

- describe biligand synthesis
- outline synthesis of peptides (i) and (ii)
- describe synthesis of peptide (iii)
- scale up synthesis of peptide (iii)

### Example 7

- describe anchor binding ELISA

### Example 8

- describe surface plasmon resonance

### Example 9

- prepare biotinylated chimera
- perform cocktail binding ELISA
- measure signal-to-noise ratio

